As of October 31, 2019, the largest concentration of Candida auris cases — 427 of 911 confirmed cases — is in New York4, according to an article on the Infection Control Today website.
“Approximately 3 years into the New York outbreak, these pan-resistant isolates still appear to be rare, but their emergence is concerning,” investigators have said.
C. auris cases in New York are primarily concentrated among hospital patients and nursing home residents in New York City.
The investigators recommended that patients on antifungal treatment for C. auris should be monitored closely for clinical improvement, and follow-up cultures should be obtained.
Silent Undercount: HAI Deaths Are Far Higher Than Reported
Ground Broken on Cleveland Clinic Avon Hospital Expansion Project in Ohio
Tennessee Oncology Opens New Tullahoma Medical Center
Rethinking Carpeting's Role in Senior Care Facilities
Parkview Health Breaks Ground on New Hospital in West Lafayette, IN